[1]
Jommi, C., Addis, A., Martini, N., Nicod, E., Pani, M., Scopinaro, A. and Vogler, S. 2021. Price and reimbursement for orphan medicines and managed entry agreements: does Italy need a framework?. Global and Regional Health Technology Assessment. 8, 1 (Aug. 2021), 114–119. DOI:https://doi.org/10.33393/grhta.2021.2278.